Market Context — Why This Technology, Why Now

Industries worldwide face increasing pressure to achieve higher purity standards, reduce waste, and improve manufacturing efficiency. This includes the pharmaceutical sector's need for ultra-pure APIs, the advanced materials market's drive for precise functionalization, and the environmental sector's mandate for effective pollutant removal. This technology provides a foundational solution to these challenges, offering a competitive edge through superior molecular control and streamlined processes.

Key Competitive Advantages
01

Achieves high molecular selectivity by precisely adjusting host molecule encapsulation capacity with lid molecules, significantly improving process purity and efficiency.

02

Simplifies manufacturing processes by enabling lid molecules, host molecules, and target molecules to coexist in a single system, eliminating complex multi-stage synthesis or purification steps, which reduces manufacturing time and costs.

03

Establishes pioneering technological superiority with only two prior art documents cited by the examiner, highlighting the technology's uniqueness and potential for early market share and standardization.

Market Opportunity
🔬 Pharmaceutical & Bioprocess
$350M–$550M globally (AI est.)
Increasing demand for high-purity active pharmaceutical ingredients (APIs) and stringent quality standards necessitate more efficient and selective purification technologies. This technology could help resolve bottlenecks in pharmaceutical manufacturing processes.
Pharmaceutical API manufacturers Biopharmaceutical companies Contract Development and Manufacturing Organizations (CDMOs)
🧪 Advanced Materials Development
$800M–$1.2B globally (AI est.)
Precise molecular assembly design is crucial for developing smart materials and high-performance catalysts that exhibit specific functionalities. This technology has the potential to accelerate the creation of novel functional materials.
Advanced chemical manufacturers Specialty polymer producers Catalyst developers Electronics materials suppliers
🌍 Environmental & Analytical Science
$550M–$800M globally (AI est.)
There is a growing need for detecting and removing trace environmental pollutants, as well as selectively recovering rare resources. This technology offers highly sensitive and efficient solutions for these applications.
Environmental remediation service providers Analytical instrument manufacturers Water treatment solution providers Resource recovery specialists
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a method for precisely modifying host molecule encapsulation capacity using specific lid molecules, enabling highly selective target molecule capture and simplified manufacturing processes. Its strong claims and minimal prior art (only 2 documents cited) indicate robust and unique intellectual property.

Competitive White Space

While this patent covers specific molecular encapsulation control, it leaves white space in advanced material processing techniques, novel adsorbent regeneration methods, or integration with AI-driven molecular design platforms for new host-guest systems.

Economic Impact
~$65K/year estimated cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

In pharmaceutical API purification or advanced materials synthesis, assuming an annual cost of ~$330K (AI est.) for conventional separation/purification processes (including labor, materials, and waste disposal), this technology could reduce costs by ~20% (an annual saving of ~$65K (AI est.)) through high selectivity and process simplification. Additionally, a ~20% reduction in process time could boost productivity and increase product revenue.

Speed to Market
6× faster than in-house development
This technology is based on clearly defined components—host molecules, lid molecules, and target molecules—with a theoretically established behavior. Proof-of-concept has been completed at the laboratory level, and the mechanism for modifying encapsulation capacity is described in detail. This allows adopting companies to bypass significant basic research, moving directly to applied development. Integration into existing material synthesis or separation processes primarily involves molecular design adjustments and process optimization, making market entry realistic within approximately six months, compared to over three years for in-house development of equivalent encapsulation control technology.
Competitive Positioning

X: Precision Molecular Control
Y: Process Simplification Efficiency

Business Models & Applications
🤝 Technology Licensing
Grant exclusive or non-exclusive licenses for this technology, allowing companies to integrate it into their products or processes. Royalty agreements ensure revenue grows with the licensee's business expansion.
🧪 Encapsulate & Functional Material OEM
Offer OEM supply of highly selective encapsulates or functional composites manufactured using this technology, tailored to specific client needs. This provides high-quality intermediate materials, contributing to product differentiation.
💡 Joint Development & R&D Partnership
Promote joint R&D programs based on this technology for specific problem-solving or new material development. Payments would be tied to development milestones, with future royalties upon commercialization.
Adjacent Application Opportunities
💊 Medical & Diagnostics
Ultra-Sensitive Biomarker Detection
Apply lid-molecule controlled encapsulation to selectively capture trace disease biomarkers in blood or urine with ultra-high sensitivity. This could contribute to early disease detection and maximize treatment efficacy through early diagnostic kits and precision medicine applications, addressing a global market for diagnostics estimated at over $100 billion.
🔋 Energy & Storage
Next-Generation Battery Materials
Utilize materials that efficiently encapsulate and de-encapsulate specific ions within electrolytes. This could enhance ion transport efficiency and stability in next-generation solid-state batteries and hydrogen storage materials, accelerating high-performance energy device development in a market projected to reach $500 billion by 2030.
💧 Environmental Remediation & Resource Recovery
Selective Pollutant Removal Systems
Selectively capture and remove specific harmful substances (e.g., heavy metal ions, volatile organic compounds) from wastewater or exhaust gases using host molecules with adjusted encapsulation capacity. This could reduce environmental impact and improve resource recycling efficiency, addressing a global environmental technology market exceeding $1 trillion.
Integration Roadmap — Estimated 18-Month Deployment
Concept Validation & Material Selection
Duration: 3 months
Select the optimal combination of host and lid molecules for the licensee's target molecules and existing processes, then conduct basic encapsulation performance verification at a laboratory scale.
Process Optimization & Pilot Testing
Duration: 6 months
Using the selected molecular system, optimize encapsulation conditions and perform process integration tests at the licensee's pilot plant scale. Measure production efficiency and purity improvement effects to gather data for mass production.
Mass Production Design & Full-Scale Implementation
Duration: 9 months
Based on pilot test results, design the application for mass production plants and proceed with full-scale implementation. Support the establishment of operational systems and technology transfer to initiate regular operation.
Technical Feasibility
This technology is expected to be relatively easy to integrate into existing chemical synthesis or separation/purification facilities. The simple step of coexisting specific host molecules, lid molecules, and target molecules within the same system may not require new large-scale capital investment, potentially utilizing existing reaction vessels or mixing systems. The primary technical hurdles involve the appropriate selection and optimization of each molecule, which is considered solvable within the scope of materials science and chemical engineering expertise.
Success Scenario
Upon adopting this technology, the efficiency of impurity separation in pharmaceutical manufacturing processes could improve by ~30% compared to current methods. This is estimated to lead to an annual manufacturing cost reduction of approximately ~$330K (AI est.) while enhancing product purity, and could also shorten time-to-market by an average of three months.
Patent Record
APPLICATION NO.
特願2022-021240
REGISTRATION NO.
7762424
FILING DATE
2022年02月15日
GRANT DATE
2025年10月22日
EXPIRATION DATE
2042年02月15日
PATENT HOLDER
国立大学法人　東京大学
Examination History
2022年04月18日
手続補正書（自発・内容）
2024年11月21日
出願審査請求書
2025年07月15日
拒絶理由通知書
2025年09月09日
意見書
2025年09月09日
手続補正書（自発・内容）
2025年10月07日
特許査定